跳至主要内容
临床试验/CTRI/2023/10/059006
CTRI/2023/10/059006尚未招募Phase 3 4

comparison of i-gelTM and ambu AuraGain as a conduit for blind endotracheal intubation in adult patients in elective surgeries.

maharaja agrasen medical college1 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2023年10月30日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
130
试验地点
1
主要终点
To compare success rate of blind endotracheal intubation through i-gelTM & Ambu AuraGain.

研究概览

简要总结

The Ambu AuraGain laryngeal mask airway (Ambu A/S, Ballerup Denmark) is a newer secondgeneration supraglottic airway device launched in June 2014. It is a single use SAD made of polyvinylchloride (PVC) and is anatomically curved to follow the human airway and promises to provide high seal pressures [Figure 1]. In addition, it has an integrated gastric access, a bite block, and a wider airway tube and can be used as conduit for direct blind intubation and fiberoptic guided intubation. The purpose of this study is to compare the blind endotracheal intubation 2 through i-gelTM and Ambu AuraGain in adults in elective surgery.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • BELONGING TO ASA PHYSICAL STATUS I OR II.

排除标准

  • Patients with pregnancy, known or predicted difficult airway, reduced lung compliance, inter incisor gap < 3.0cm, BMI >35 kg/m2 , High risk for pulmonary aspiration (non fasted, gastroesophageal reflux disease).

结局指标

主要结局

To compare success rate of blind endotracheal intubation through i-gelTM & Ambu AuraGain.

时间窗: 48weeks

次要结局

  • 1. To compare success rate of device [SAD] insertion [Number of insertion attempts, time of(insertion].)

研究者

发起方
maharaja agrasen medical college
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验